Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

K V Pharma CL A (KVA)

K V Pharma CL A
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:KVA
DateTimeSourceHeadlineSymbolCompany
18/06/201214:04Dow Jones NewsU.S. HOT STOCK FUTURES: HOT STOCKS to WATCHNYSE:KVAK V Pharma CL A
18/06/201212:08Dow Jones NewsU.S. HOT STOCK FUTURES: HOT STOCKS to WATCHNYSE:KVAK V Pharma CL A
17/11/201101:15Business WireGlancy Binkow & Goldberg LLP Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against K-V Pharmaceutical CompanyNYSE:KVAK V Pharma CL A
03/11/201101:40Business WireLaw Offices of Howard G. Smith Announces Class Action Lawsuit Against K-V Pharmaceutical CompanyNYSE:KVAK V Pharma CL A
01/11/201101:30Business WireGlancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against K-V Pharmaceutical CompanyNYSE:KVAK V Pharma CL A
28/10/201121:30Business WireFaruqi & Faruqi, LLP Announces Investigation of K-V Pharmaceutical CompanyNYSE:KVAK V Pharma CL A
24/10/201118:52Business WireThe Briscoe Law Firm and Powers Taylor, LLP Announce Investigation of K-V Pharmaceutical CompanyNYSE:KVAK V Pharma CL A
21/10/201101:47Business WireLaw Offices of Howard G. Smith Announces Class Action Lawsuit Against K-V Pharmaceutical CompanyNYSE:KVAK V Pharma CL A
13/10/201114:02Business WireZeldes & Haeggquist, LLP Announces Investigation of K-V PharmaceuticalNYSE:KVAK V Pharma CL A
13/06/201113:00PR Newswire (US)K-V Pharmaceutical Company Announces Filing of Fiscal 2011 Form 10-K and Schedules Investor Conference CallNYSE:KVAK V Pharma CL A
01/04/201120:08Dow Jones NewsUPDATE: K-V Pharma Slashes Price Of Preterm Labor Drug Amid OutcryNYSE:KVAK V Pharma CL A
01/04/201115:28Dow Jones NewsK-V Pharma Slashes Prices Of Preterm Labor Drug After FDA MoveNYSE:KVAK V Pharma CL A
31/03/201122:28Dow Jones NewsReligious Groups Urge Drug Makers To Ease Up On Price HikesNYSE:KVAK V Pharma CL A
30/03/201120:58Dow Jones NewsUPDATE: K-V Pharma Shares Drop On FDA Statement On Preterm Birth DrugNYSE:KVAK V Pharma CL A
30/03/201117:38Dow Jones NewsK-V Pharma Shares Drop On FDA Statement On Preterm Birth DrugNYSE:KVAK V Pharma CL A
01/03/201113:49PR Newswire (US)K-V Pharmaceutical Company Announces $200 Million Private Debt OfferingNYSE:KVAK V Pharma CL A
14/02/201115:36PR Newswire (US)KV Pharmaceutical Company Announces Delay In Conference Call and Provides Overview Of Conference Call CommentsNYSE:KVAK V Pharma CL A
14/02/201115:34PR Newswire (US)K-V Pharmaceutical Company Announces Reliance on the Financial Distress Exception to NYSE's Shareholder Approval Policy to IssueNYSE:KVAK V Pharma CL A
14/02/201114:48PR Newswire (US)K-V Pharmaceutical Company Announces Completion of a $32 Million Private Placement of Class A Common StockNYSE:KVAK V Pharma CL A
04/02/201113:40PR Newswire (US)K-V Pharmaceutical Company to Host Investor Conference Call on February 14, 2011NYSE:KVAK V Pharma CL A
12/01/201114:03PR Newswire (US)K-V Pharmaceutical Company Updates Status of New Drug Application for Gestivaâ„¢NYSE:KVAK V Pharma CL A
14/09/201015:29Dow Jones NewsK-V Pharmaceutical Enters Loan Agreement In Wake Of FDA ApprovalNYSE:KVAK V Pharma CL A
10/09/201014:53Dow Jones NewsK-V Pharma Soars On FDA Approval To Return Product To MarketNYSE:KVAK V Pharma CL A
25/02/201018:53PR Newswire (US)KV Pharmaceutical Reaches Agreement with U.S. Department of JusticeNYSE:KVAN^CURN
28/01/201022:04Business WireRobbins Umeda LLP Announces Investigation of KV Pharmaceutical CompanyNYSE:KVAK V Pharma CL A
20/01/201020:41Dow Jones NewsUPDATE: Watson Pharma Benefits From Toprol Market PresenceNYSE:KVAK V Pharma CL A
20/01/201019:11Dow Jones NewsWatson Pharma Continues To Benefit From Toprol Market PresenceNYSE:KVAK V Pharma CL A
11/01/201014:18PR Newswire (US)KV Pharmaceutical Amends Agreement to Secure Rights to Gestiva(TM)NYSE:KVA
07/01/201021:10PR Newswire (US)KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes to Approve Appointment of DirectorNYSE:KVA
22/12/200922:34PR Newswire (US)KV Pharmaceutical Receives Permission from NYSE for its Securities to Continue Trading on the NYSE until March 31, 2010NYSE:KVA
 Showing the most relevant articles for your search:NYSE:KVA